{"transactions":[{"id":680003,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":27052,"price":1.4199,"value":38411.1348,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.47, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":680002,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":222948,"price":1.4199,"value":316563.8652,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.47, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":680001,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":27051,"price":1.4407,"value":38972.3757,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27052,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":680000,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":222949,"price":1.4407,"value":321202.6243,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":222948,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":679999,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":27826,"price":1.3712,"value":38155.0112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.345 to $1.40, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54103,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":679998,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":229338,"price":1.3712,"value":314468.2656,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.345 to $1.40, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":445897,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":694273,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney Holdings, LLC","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":675235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":675235},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694272,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":675235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Class B Common Stock and the Common Units in ProKidney Holdings LLC (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each share of Class B Common Stock, together with a paired Common Unit, may be exchanged for a share of Class A Common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":675235},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694271,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney Holdings, LLC","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":81929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":81929},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694270,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":81929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Class B Common Stock and the Common Units in ProKidney Holdings LLC (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each share of Class B Common Stock, together with a paired Common Unit, may be exchanged for a share of Class A Common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":81929},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694269,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":true,"shares":675235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"balance_after":675235,"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694268,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":true,"shares":81929,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81929,"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":741472,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests over a 12 month period: 1/12th on November 1, 2025, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":12.05,"expiration_date":"2035-09-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":741471,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.54,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":741470,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.08,"expiration_date":"2033-09-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":741469,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.53,"expiration_date":"2032-10-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":741468,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.45,"expiration_date":"2031-09-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":741467,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.88,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":741466,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:40:14.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.95,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001298146-26-000002","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814626000002/form4-06112026_080609.xml","form_type":"4"}},{"id":758839,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:03:34.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248215/ownership.xml","form_type":"4"}},{"id":998961,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":54333,"price":2.37,"value":128769.21,"ownership":{"direct":false,"nature":"Brian J. G. Pereira 2004 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":998960,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":447803,"price":2.37,"value":1061293.11,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":998959,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":27595,"price":2.7234,"value":75152.223,"ownership":{"direct":false,"nature":"Brian J. G. Pereira 2004 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54333,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":998958,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":227431,"price":2.7233,"value":619362.8423,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":447803,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":1026754,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-02T22:31:30.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 1, 2025, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":12.05,"expiration_date":"2035-09-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001298146-25-000004","document":"form4-10022025_101026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000129814625000004/form4-10022025_101026.xml","form_type":"4"}},{"id":1127795,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:14:20.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080269/ownership.xml","form_type":"4"}},{"id":1280385,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":675234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":675235,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":675234},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280384,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":675234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":675235,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":675234},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280383,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":81929,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280382,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":81929,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280381,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":true,"shares":675234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"balance_after":675234,"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280380,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":true,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81928,"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1390698,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T20:08:14.000Z","date":"2024-10-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12-month period: 1/12th on November 3, 2024, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":11.54,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-024751","document":"form4-10042024_081011.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000141588924024751/form4-10042024_081011.xml","form_type":"4"}},{"id":1495282,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:32:59.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068043","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068043/ownership.xml","form_type":"4"}},{"id":1772070,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-28T20:53:34.000Z","date":"2023-09-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on October 26, 2023, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.08,"expiration_date":"2033-09-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-050754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000120919123050754/doc4.xml","form_type":"4"}},{"id":1839820,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2023-07-03T13:18:12.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":48128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":48128,"derivative":{"exercise_price":10.56,"expiration_date":"2033-06-29","underlying":"Class A Ordinary Shares","underlying_shares":48128},"source":{"system":"sec-edgar","filing":"0001209191-23-040424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000120919123040424/doc4.xml","form_type":"4"}},{"id":2136252,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-17T22:35:33.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on October 13, 2022, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":4.53,"expiration_date":"2032-10-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-053876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000120919122053876/doc4.xml","form_type":"4"}},{"id":2208113,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2022-07-14T01:32:51.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":1514326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."}],"balance_after":1514326,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1514326},"source":{"system":"sec-edgar","filing":"0000950103-22-012376","document":"dp177030_4-pereira.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012376/dp177030_4-pereira.xml","form_type":"4"}},{"id":2208112,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2022-07-14T01:32:51.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":1514326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Class B Ordinary Share has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the Securities and Exchange Commission on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (\"ProKidney\") (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."}],"balance_after":1514326,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1514326},"source":{"system":"sec-edgar","filing":"0000950103-22-012376","document":"dp177030_4-pereira.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012376/dp177030_4-pereira.xml","form_type":"4"}},{"id":2554217,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-10-01T20:55:16.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on October 30, 2021, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":17.45,"expiration_date":"2031-09-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-058486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000120919121058486/doc4.xml","form_type":"4"}},{"id":3015908,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-10-03T00:36:12.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 1, 2020, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":12.88,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-053395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000120919120053395/doc4.xml","form_type":"4"}},{"id":3174801,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-17T23:03:31.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":930000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on April 15, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":930000,"derivative":{"exercise_price":2.5,"expiration_date":"2030-04-15","underlying":"Common Stock","underlying_shares":930000},"source":{"system":"sec-edgar","filing":"0001493152-20-006669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220006669/ownership.xml","form_type":"4"}},{"id":3673972,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-02-05T22:41:13.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 3 year period: 1/36th vests on March 1, 2019, after which 1/36th of the total shares vest monthly, subject to reporting person's continued service through each vesting date."}],"balance_after":14000,"derivative":{"exercise_price":17.95,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-002402","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298146/000156761919002402/doc1.xml","form_type":"4"}}]}